IP Library Granted Patent US 8,691,205
Granted Patent B2
US 8,691,205 · App. 13/140,390 · Granted Apr 8, 2014

Mono- and di-PEG IL-10 production; and uses

Inventors: Steven J. Blaisdell (Jackson, NJ); Collette M. Cutler (Bloomingdale, NJ); Brittany C. Paporello (Martinsville, NJ); Alexandre Ambrogelly (Westfield, NJ)
Assignee: Merck Sharp & Dohme Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,205
App. No.
13/140,390
Granted
Apr 8, 2014
Kind
B2
Abstract

Provided are methods of producing a mixture of mono- and di-pegylated IL-10.

Claims (79)

1. A method of producing a mixture of mono- and di-pegylated interleukin-10 (IL-10), wherein at least one PEG molecule is covalently attached to at least one amino acid residue of at least one subunit of IL-10, comprising:

a) reacting 1 mg/ml to 12 mg/ml of IL-10 with an activated PEG-linker such that the IL-10 to PEG-linker ratio is 1:3.5, in the presence of 25 mM to 35 mM of a reducing agent; and

b) purifying the mixture of mono- and di-pegylated IL-10.

2. The method of claim 1 , wherein the PEG-linker is selected from the group consisting of succinimidylcarbonate-PEG, PEG-butyraldehyde, PEG-pentaldehyde, PEG-amido-propionaldehyde, PEG-urethano-propioaldehyde, and PEG-propylaldehyde.

3. The method of claim 2 , wherein the PEG-linker is PEG-propylaldehyde.

4. The method of claim 1 , wherein the molecular mass of PEG comprising the PEG-linker is from 5,000 daltons to 20,000 daltons.

5. The method of claim 4 , wherein the molecular mass of PEG comprising the PEG linker is 5,000 daltons.

6. The method of claim 1 , wherein the reducing agent is selected from the group consisting of borohydride, sodium cyanoborohydride, amine borane, and picoline borane.

7. The method of claim 6 , wherein the reducing agent is selected from the group consisting of sodium cyanoborohydride and picoline borane.

8. The method of claim 1 , wherein the mixture of mono- and di-PEG is purified by chromatography selected from the group consisting of cation exchange, anion exchange, size exclusion, and hydrophobic interaction.

9. The method of claim 8 , wherein the mixture of mono- and di-PEG is purified by size exclusion chromatography.

10. The method of claim 1 , wherein the reacting is at a pH of about 5.0-7.4.

11. The method of claim 10 , wherein the pH is 6.3.

12. The method of claim 1 , wherein the reacting is at a temperature of 5° C. to 30° C.

13. The method of claim 12 , wherein the temperature is 15° C.

14. The method of claim 1 , wherein the reacting is for 3-24 hours.

15. The method of claim 14 , wherein the reacting is for 12-19 hours.

16. The method of claim 14 , wherein the reacting is for 12-18 hours.

17. The method of claim 14 , wherein the reacting is for 15-19 hours.

18. The method of claim 14 , wherein the reacting is for 15-18 hours.

19. The method of claim 1 , wherein the reacting is in the presence of 25 mM of a reducing agent.

20. A method of producing a mixture of mono- and di-pegylated interleukin-10 (IL-10), wherein at least one PEG molecule is covalently attached to at least one amino acid residue of at least one subunit of IL-10, comprising:

a) reacting 1 mg/ml to 12 mg/ml of IL-10 with an activated PEG-linker in the presence of 25 mM to 35 mM of a reducing agent; and

b) purifying the mixture of mono- and di-pegylated IL-10.

21. The method of claim 20 , wherein the ratio of IL-10 to PEG linker is 1:1-1:7.7.

22. The method of claim 21 , wherein the ratio is 1:3.5.

23. The method of claim 20 , wherein the reacting is at a pH of about 5.0-7.4.

24. The method of claim 23 , wherein the pH is 6.3.

25. The method of claim 20 , wherein the reacting is at a temperature of 5° C. to 30° C.

26. The method of claim 25 , wherein the temperature is 15° C.

27. The method of claim 20 , wherein the reacting is for 3-24 hours.

28. The method of claim 27 , wherein the reacting is for 12-19 hours.

29. The method of claim 27 , wherein the reacting is for 12-18 hours.

30. The method of claim 27 , wherein the reacting is for 15-19 hours.

31. The method of claim 27 , wherein the reacting is for 15-18 hours.

32. The method of claim 20 , wherein the PEG-linker is PEG-propylaldehyde.

33. The method of claim 20 , wherein the molecular mass of PEG comprising the PEG-linker is from 5,000 daltons to 20,000 daltons.

34. The method of claim 33 , wherein the molecular mass of PEG comprising the PEG linker is 5,000 daltons.

35. The method of claim 20 , wherein the reducing agent is selected from the group consisting of borohydride, sodium cyanoborohydride, amine borane, and picoline borane.

36. The method of claim 35 , wherein the reducing agent is selected from the group consisting of sodium cyanoborohydride and picoline borane.

37. The method of claim 20 , wherein the mixture of mono- and di-PEG is purified by chromatography selected from the group consisting of cation exchange, anion exchange, size exclusion, and hydrophobic interaction.

38. The method of claim 37 , wherein the mixture of mono- and di-PEG is purified by size exclusion chromatography.

39. The method of claim 20 , wherein the method produces a 1:1 ratio of mono-pegylated IL-10 to di-pegylated IL-10.

40. The method of claim 20 , wherein the reacting is in the presence of 25 mM of a reducing agent.

41. A method of producing a mixture of mono- and di-pegylated interleukin-10 (IL-10), comprising:

a) reacting IL-10 with an activated PEG-linker in the presence of a reducing agent, wherein the IL-10 and the reducing agent are present in a molar ratio of 0.0009 to 0.04; and

b) purifying the mixture of mono- and di-pegylated IL-10.

42. The method of claim 41 , wherein the ratio of IL-10 to PEG linker is 1:1-1:7.7.

43. The method of claim 42 , wherein the ratio of IL-10 to PEG linker is 1:3.5.

44. The method of claim 41 , wherein the reacting is at a pH of about 5.0-7.4.

45. The method of claim 44 , wherein the pH is 6.3.

46. The method of claim 41 , wherein the reacting is at a temperature of 5° C. to 30° C.

47. The method of claim 46 , wherein the temperature is 15° C.

48. The method of claim 41 , wherein the reacting is for 3-24 hours.

49. The method of claim 48 , wherein the reacting is for 12-19 hours.

50. The method of claim 48 , wherein the reacting is for 12-18 hours.

51. The method of claim 48 , wherein the reacting is for 15-19 hours.

52. The method of claim 48 , wherein the reacting is for 15-18 hours.

53. The method of claim 41 , wherein the PEG-linker is PEG-propylaldehyde.

54. The method of claim 41 , wherein the molecular mass of PEG comprising the PEG-linker is from 5,000 daltons to 20,000 daltons.

55. The method of claim 54 , wherein the molecular mass of PEG comprising the PEG linker is 5,000 daltons.

56. The method of claim 41 , wherein the reducing agent is selected from the group consisting of borohydride, sodium cyanoborohydride, amine borane, and picoline borane.

57. The method of claim 56 , wherein reducing agent is selected from the group consisting of sodium cyanoborohydride and picoline borane.

58. The method of claim 41 , wherein the mixture of mono- and di-pegylated IL-10 is purified by chromatography selected from the group consisting of cation exchange, anion exchange, size exclusion, and hydrophobic interaction.

59. The method of claim 58 , wherein the mixture of mono- and di-pegylated IL-10 is purified by size exclusion chromatography.

60. The method of claim 41 , wherein the method produces a 1:1 ratio of mono-pegylated IL-10 to di-pegylated IL-10.

61. The method of claim 41 , wherein the molar ratio of IL-10 to reducing agent is 0.0009-0.01.

62. The method of claim 61 , wherein the reacting is at a pH of about 5.0-7.4.

63. The method of claim 62 , wherein the pH is 6.3.

64. The method of claim 61 , wherein the reacting is at a temperature of 5° C. to 30° C.

65. The method of claim 64 , wherein the temperature is 15° C.

66. The method of claim 61 , wherein the reacting is for 3-24 hours.

67. The method of claim 66 , wherein the reacting is for 12-19 hours.

68. The method of claim 66 , wherein the reacting is for 12-18 hours.

69. The method of claim 66 , wherein the reacting is for 15-19 hours.

70. The method of claim 66 , wherein the reacting is for 15-18 hours.

71. The method of claim 41 , wherein the molar ratio of IL-10 to reducing agent is 0.006-0.04.

72. The method of claim 41 , wherein the molar ratio of IL-10 to reducing agent is 0.006-0.01.

73. The method of claim 41 , wherein the molar ratio of IL-10 to reducing agent is 0.008.

Assignments (2)
CHANGE OF NAME Recorded Feb 7, 2013
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 029777/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2012
From: BLAISDELL, STEVEN J.; CUTLER, COLLETTE M.; PAPORELLO, BRITTANY C.; AMBROGELLY, ALEXANDRE
To: SCHERING CORPORATION
Reel/Frame 027774/0656 →
Continuity (3)
Provisional Application 61138421 · Dec 17, 2008
Provisional Application 61245182 · Sep 23, 2009
Related Publication 20110250163A1 · Oct 13, 2011